The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, October 27, 2020
Enlivex reported the first two patients have been dosed in an investigator-initiated Phase II clinical trial evaluating Allocetra in severe and ...
read more
Wednesday, October 28, 2020
Bayer AG and Asklepios BioPharmaceutical (AskBio) announced an agreement under which Bayer will acquire AskBio.
read more
Wednesday, October 28, 2020
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled ...
read more
Wednesday, October 28, 2020
Vanessa Research (VR) has been granted positive orphan drug opinion by the EMA for their drug Shylicine.
read more
Wednesday, October 28, 2020
TrippBio is developing a patent-pending repurposed FDA-approved drug, TD213.
read more
Wednesday, October 28, 2020
BiondVax Pharmaceuticals announced topline data from the Company's pivotal, phase 3 clinical trial of M-001 as a standalone universal flu vaccine ...
read more
Thursday, October 29, 2020
NBE-Therapeutics has commenced first-in-human studies of its lead program NBE-002 targeting ROR1, for triple negative breast cancer and other solid ...
read more
Thursday, October 29, 2020
Aeglea BioTherapeutics announced the FDA has granted Orphan Drug Designation to ACN00177 for the treatment of Homocystinuria.
read more
Seelos has been issued U.S. patent number 10815271 from the USPTO covering the composition of matter for SLS-007.
read more
The FDA has approved the NGS-based FoundationOne CDx test as a companion diagnostic to identify fusions in NTRK genes, NTRK1, NTRK2, and NTRK3, in DNA...
read more
Vanda announced the FDA has approved the IND application to evaluate Cystic Fibrosis Transmembrane Conductance Regulator activator VSJ-110 for ...
read more
Monday, November 02, 2020
Agenus announced the dosing of the first COVID-19 patient with agenT-797, an allogeneic cell therapy, through its subsidiary, AgenTus Therapeutics.
read more
Monday, November 02, 2020
RevImmune announced its "ILIAD-7" international randomized controlled Phase 2 trial in patients critically ill with COVID-19, is now enrolling ...
read more
Tuesday, November 03, 2020
Oncolytics Biotech announced a new multi-indication gastrointestinal cancer study to be managed by AIO.
read more
Tuesday, November 03, 2020
Syntrix Pharmaceuticals has completed initial SX-682 dosing in Phase 1/2 trials in myelodysplastic syndromes (MDS) and metastatic melanoma.
read more